Literature DB >> 28244998

Worth the RISC?

Ken Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28244998     DOI： 10.1038/nbt.3810

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

1.  Theranostic Nanoparticles for RNA-Based Cancer Treatment.

Authors:  Richard A Revia; Zachary R Stephen; Miqin Zhang
Journal:  Acc Chem Res       Date:  2019-05-28       Impact factor: 22.384

2.  With Alnylam's amyloidosis success, RNAi approval hopes soar.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2017-11-09       Impact factor: 54.908

Review 3.  Tapping the RNA world for therapeutics.

Authors:  Judy Lieberman
Journal:  Nat Struct Mol Biol       Date:  2018-04-16       Impact factor: 15.369

4.  Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.

Authors:  Jagadish Beloor; Nyree Maes; Irfan Ullah; Pradeep Uchil; Andrew Jackson; Erol Fikrig; Sang Kyung Lee; Priti Kumar
Journal:  Cell Host Microbe       Date:  2018-03-29       Impact factor: 21.023

5.  Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale.

Authors:  Prasath Paramasivam; Christian Franke; Martin Stöter; Andreas Höijer; Stefano Bartesaghi; Alan Sabirsh; Lennart Lindfors; Marianna Yanez Arteta; Anders Dahlén; Annette Bak; Shalini Andersson; Yannis Kalaidzidis; Marc Bickle; Marino Zerial
Journal:  J Cell Biol       Date:  2021-12-09       Impact factor: 10.539

6.  Synthesis, gene silencing activity, thermal stability, and serum stability of siRNA containing four (S)-5'-C-aminopropyl-2'-O-methylnucleosides (A, adenosine; U, uridine; G, guanosine; and C, cytidine).

Authors:  Ryohei Kajino; Shuichi Sakamoto; Yoshihito Ueno
Journal:  RSC Adv       Date:  2022-04-12       Impact factor: 3.361

7.  Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.

Authors:  Wen Shen; Cheryl L De Hoyos; Hong Sun; Timothy A Vickers; Xue-Hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

8.  As Technologies for Nucleotide Therapeutics Mature, Products Emerge.

Authors:  Jennifer M Beierlein; Laura M McNamee; Fred D Ledley
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.